Open access
Research Article
13 September 2013

Mutation of RNA Polymerase β-Subunit Gene Promotes Heterogeneous-to-Homogeneous Conversion of β-Lactam Resistance in Methicillin-Resistant Staphylococcus aureus

ABSTRACT

Three types of phenotypic expression of β-lactam resistance have been reported in methicillin-resistant Staphylococcus aureus (MRSA): heterogeneous, homogeneous, and Eagle-type resistance. Heterogeneous-to-homogeneous conversion of β-lactam resistance is postulated to be caused by a chromosomal mutation (chr*) in addition to the expression of the mecA gene. Eagle-type resistance is a unique phenotype of chr* occurring in pre-MRSA strain N315 whose mecA gene expression is strongly repressed by an intact mecI gene. We here report that certain mutations of the rpoB gene, encoding the RNA polymerase β subunit, belong to chr*. We studied homogeneous MRSA (homo-MRSA) strain N315ΔIP-H5 (abbreviated as ΔIP-H5), which was obtained from hetero-MRSA strain N315ΔIP by selection with 8 mg/liter imipenem. Whole-genome sequencing of ΔIP-H5 revealed the presence of a unique mutation in the rpoB gene, rpoB(N967I), causing the amino acid replacement of Asn by Ile at position 967 of RpoB. The effect of the rpoB(N967I) mutation was confirmed by constructing a revertant H5 rpoB(I967N) strain as well as an N315-derived mutant, N315 rpoB(N967I). H5 rpoB(I967N) regained the hetero-resistance phenotype, and the N315 rpoB(N967I) strain showed an Eagle-type phenotype similar to that of the typical Eagle-type MRSA strain N315h4. Furthermore, subsequent whole-genome sequencing revealed that N315h4 also had a missense mutation of rpoB(R644H). Introduction of the rpoB(N967I) mutation was accompanied by decreased autolysis, prolonged doubling time, and tolerance to bactericidal concentrations of methicillin. We consider that rpoB mutations are the major cause for heterogeneous-to-homogeneous phenotypic conversion of β-lactam resistance in MRSA strain N315 and its derived strains.

INTRODUCTION

Methicillin resistance in staphylococcal species is mediated by production of penicillin-binding protein 2′ (PBP2′) (or PBP2a), the β-lactam-insensitive cell wall synthesis enzyme encoded by the mecA gene (15). Since most of the clinically used β-lactam antibiotics do not bind to PBP2′ appreciably at therapeutic concentrations, they are ineffective in the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA). However, the production of PBP2′ alone dose not make the cells uniformly resistant to β-lactam. The expression of PBP2′ makes the bacterial strain a mixture of cell subpopulations with different levels of β-lactam resistance. This peculiar resistance phenotype is known as heterogeneous methicillin resistance (hetero-type resistance). Exposure of the hetero-MRSA strain to β-lactam antibiotics selects out mutant strains whose entire cell populations are uniformly highly resistant to β-lactam antibiotics. The resistance phenotype is called homogeneous methicillin resistance (homo-type resistance). Ryffel et al. and Berger-Bachi and Rohrer postulated the occurrence of a spontaneous chromosomal mutation (chr*) that is responsible for heterogeneous-to-homogeneous conversion of methicillin resistance (6, 7). The mutation chr* was considered unlinked to the mecA gene complex, which was acquired exogenously as a mobile genetic element (6).
The third phenotype of β-lactam resistance, called Eagle type, is known for an unusual distribution of resistant cell subpopulations, as revealed by population analysis (8, 9). Eagle-type MRSA grows better on agar plates containing high concentrations of methicillin than on those with low concentrations of methicillin (10). The phenotype is observed only in the rare category of strains called pre-MRSA (11, 12). Despite the presence of an intact mecA gene, pre-MRSA is methicillin susceptible (oxacillin MIC of <4 mg/liter) since PBP2′ is not expressed due to the repressor function encoded by the mecI gene (11, 13). Pre-MRSA N315 is a typical Japanese hospital-acquired MRSA strain belonging to staphylococcal cassette chromosome mec (SCCmec) type II (subtype 2A; ccr gene complex type 2 and mec complex class A) (1416) and sequence type 5 (17). Selection of N315 with low concentrations (10 mg/liter) of methicillin yields a hetero-MRSA strain (12). On the other hand, selection of N315 with a high concentration (≥128 mg/liter) of methicillin yields an Eagle-type strain (10). Subsequent inactivation of the mecI gene converts the Eagle-type MRSA to homo-MRSA strain (10). The experiments indicated that the genetic event converts pre-MRSA to Eagle-type MRSA, which is equivalent to chr* mutation in homo-MRSA. The experiments also indicated that tolerance to high concentrations of methicillin is associated with chr* mutation. Therefore, derepressed expression of PBP2′ and high-dose methicillin tolerance are the two requisites for homogeneous methicillin resistance (10).
The search for chr* has been our long-term interest. So far, four genes, llm, lytH, hmrA, and hmrB, have been isolated for which either activation or inactivation causes heterogeneous-to-homogeneous phenotypic conversion (7, 10, 18, 19). We previously reported that we cloned two genes, hmrA and hmrB, as the genes associated with the chr* phenotype. Overexpression of hmrA or hmrB converts hetero-MRSA to homo-MRSA and converts pre-MRSA to Eagle-type MRSA (10). Then we found the mutation vraS(S329L) in a transcription regulator that converted hetero-MRSA strain N315ΔIP into a homo-MRSA strain, with a concomitant rise in vancomycin resistance (20). The mutation vraS (S329L) caused constitutive expression of cell wall synthesis that rationally increased resistance to cell wall inhibitor antibiotics. This was the gene that satisfied the criteria for chr* mutation. In this study, we report that mutation in rpoB encoding the β subunit of RNA polymerase holoenzyme constitutes another category of chr*. We have previously proposed that rpoB mutation is a regulatory mutation that influences the susceptibility of the cell to vancomycin (21, 22), daptomycin (23, 24), and linezolid (22). Here, we further extend our view that rpoB mutation can also influence β-lactam resistance, conferring both homogeneous methicillin resistance and Eagle-type methicillin resistance to S. aureus cells, depending on the mode of expression of the mecA gene.

MATERIALS AND METHODS

Bacterial strains, plasmids, and growth conditions.

S. aureus and plasmids used in this study are listed in Table 1. The cloning and transformation of Escherichia coli strain DH5α were carried out by standard techniques (TaKaRa-Bio Co., Ltd., Shiga, Japan). All S. aureus strains were grown in brain heart infusion (BHI) broth or agar (Becton, Dickinson and Co.[BD], Franklin Lakes, NJ), with aeration at 37°C for over 18 h. The antibiotics ampicillin (Wako Pure Chemical Industries, Osaka, Japan), chloramphenicol (Sigma Chemical Co., St. Louis, MO), methicillin (SmithKline Beecham/GlaxoSmithKline, London, United Kingdom), and imipenem (WAKO) were used in this study.
Table 1
Table 1 Bacterial strains and plasmids used in this study
Strain or plasmidDescriptionaβ-Lactam resistance phenotypeReference(s)
Strains   
    N315Japanese clinical pre-MRSA strain carrying a functional mecI encoding mecA gene repressorPre-MRSA11
    N315ΔIPmecI null mutant derived from N315P, an N315-derivative strain with the penicillinase plasmid eliminatedHetero-type12
    ΔIP-H5Mutant derived from N315ΔIP by selection with 8 mg/liter of imipenem, carrying rpoB(N967I)Homo-type30
    ΔIP-H14Mutant derived from N315ΔIP by selection with 8 mg/liter of imipenem, carrying vraS(S329L)Homo-type20, 30
    N315h4Mutant derived from N315 by selection with 128 mg/liter of methicillinEagle-type10
    H5 rpoB(I967N)ΔIP-H5 in which rpoB(I967) is replaced by the wild-type rpoBHetero-typeThis study
    N315 rpoB(N967I)N315 whose wild-type rpoB is replaced by rpoB(967I) mutationEagle-typeThis study
Plasmids   
    pKOR1E. coli-S. aureus shuttle vector for construction of allelic replacement 26
    pKOR1-rpoB(967I)pKOR1 harboring the 1,820-bp PCR product of mutated rpoB carrying amino acid residue Ile at position 967 This study
    pKOR1-rpoB(967N)pKOR1 harboring the 1,820-bp PCR product of wild-type rpoB carrying amino acid residue Asn at position 967 This study
a
Strains obtained by antibiotic selection are denoted as mutant.

DNA methods.

The standard methods of DNA manipulations were described previously (25). Genomic DNAs and plasmid were prepared with Miniamp and Miniprep kits (Qiagen, Inc., Valencia, CA). Restriction enzymes were used as recommended by the manufacturer (TaKaRa). Routine PCR amplification was performed with an Expand High-Fidelity system (Roche, Mannheim, Germany).

Whole-genome sequencing of ΔIP-H5 and SNP analysis compared to the sequence of parent strain N315ΔIP.

Sequencing of the genome of strain N315ΔIP-H5 (abbreviated as ΔIP-H5) was performed with a Genome Sequencer 20 system, a recently introduced highly parallel genome sequencer from 454 Life Sciences (Branford, CT). The sequence assembly and gap closing were carried out as described previously (20). Since ΔIP-H5 is an in vitro derivative of N315, the resulting sequence of the ΔIP-H5 genome was then compared to that of N315, and then the discovery of genome-wide single nucleotide polymorphisms (SNPs) was achieved by whole-genome alignments with the Mummer (version 3.20) software package (http://mummer.sourceforge.net/). PCR amplification and sequencing of ΔIP-H5 chromosomal DNA found no additional mutations except for an rpoB mutation, which causes the replacement of a single amino acid, Asn 967, with Ile (N967I).

SNP analysis.

To analyze SNPs of three strains, H5 rpoB(I967N), N315 rpoB(N967I), and N315h4, 90-bp paired-end read sequencing was performed using a Hiseq2000 sequencing platform (Illumina Inc., San Diego, CA) at the infoBio company (Tokyo, Japan). Sequences of 90-bp paired-end reads from each bacterial strain were obtained in a single lane of a flow cell. Image analysis was performed with Illumina's Pipeline Analysis software, version 1.8. The 15.1-Mb, 18.2-Mb, and 15.9-Mb reads were obtained from the chromosomal DNA library of strains H5 rpoB(I967N), N315 rpoB(N967I), and N315h4, respectively. As de novo DNA analysis, each read was mapped to the reference whole-genome sequence of N315, and then mapping of SNPs was extracted by using the software Genome Traveler (in silico Biology Inc., Yokohama, Japan).

Construction of mutant strains N315 rpoB(N967I) and H5 rpoB(I967N).

For the chromosomal allele replacement of rpoB(N967I) in N315 or rpoB(I967N) in ΔIP-H5, we used the pKOR1 allele replacement system, as described previously (26). In brief, a 3.0-kb of rpoB insert DNA encompassing a 1-kb flanking sequence of a phage attachment site was generated by PCR from chromosomal DNA of strain N315 or ΔIP-H5 by using the following primers: attB1-rpoB (5′-GGGGACAAGTTTGTACAAAAAAAGCAGGCT-3′) and attB2-rpoB (5′-GGGGACCACTTTGTACAAGAAAGCTGGGT-3′). The resulting plasmid, pKO-rpoB(967I) or pKO-rpoB(967N) was introduced into S. aureus N315 or ΔIP-H5 by electroporation, generating transformant N315(pKO-rpoB[967I]) or ΔIP-H5(pKO-rpoB[967N]). The replacement of the rpoB gene was carried out by a two-step procedure. We identified the desired strains H5 rpoB(I967N) and N315 rpoB(N967I) by determination of the nucleotide sequence using the following three primers; 5′-CAGCTGGATGGCAAATAATG-3′, 5′-TGTGGAATTGTGAGCGGATA-3′, and 5′-AATTGCGCTTTACCGCCAAGTGGTTGT-3′. Also we confirmed the absence of other additional mutations in the mutants by SNP analysis, except for a mutation of sa0168(M199V) in N315 rpoB(N967I).

Antibiotic susceptibility.

The susceptibility of several antibiotics was examined by Etest (AB Biodisk, Solna, Sweden) and population analysis, as described previously (10). All examinations were performed by using BHI broth or agar plates.

Transmission electron microscopy.

The preparation and the examination of S. aureus cells by transmission electron microscopy were performed as described previously (22, 27). At least 120 cells of each sample with nearly equatorial cut surfaces were measured for the evaluation of cell wall thickness, and the results were expressed as the means ± standard deviations.

Doubling time.

The doubling time was calculated, as described previously (22). The growth conditions were 37°C with shaking at 25 rpm in a TN-2612 incubator (Advantec, Osaka, Japan). The optical density at 660 nm (OD660) versus time was plotted for each strain in the exponential growth phase. A linear regression curve was obtained from values between the log2 OD660 and the log2 t, where t is time (R ≥ 0.999). The doubling time was calculated follows: doubling time = [(t2t1) × log2]/(log OD660 at t2 − log OD660 at t1), where t1 and t2 are the times at the start and the end of the logarithmic growth phase. At least three independent experiments were carried out.

Autolysis assay.

Triton X-100-stimulated autolysin activity in Tris-HCl buffer (pH 7.5) was measured as described previously (28). Cells were grown to mid-exponential phase to an OD660 of about 1.5, with a cultivation temperature of 37°C. The culture was rapidly chilled, and cells were washed twice with ice-cold distilled water and suspended to an OD660 of 1.5 in 50 mM Tris-HCl buffer supplemented with 0.05% Triton X-100. Autolysis was measured during incubation at 30°C as a decrease in the OD660 by using a model TN-2612 biophotorecorder (Advantec Osaka, Japan). All data from the autolysis experiments are reported as percentages of the initial turbidity (at the zero time point) and are representative of three independent experiments.

RNA preparation and microarray analysis.

RNA extraction, cDNA labeling, hybridization, and data analysis for microarray analysis were carried out according to protocols described previously (29).

Western blot analysis.

The strains were assayed for PBP2′ production by Western blotting. S. aureus membrane proteins were prepared from mid-exponential-stage cultures. An overnight culture (0.1 ml each) was inoculated into 15 ml of fresh BHI broth and allowed to grow to an optical density at 660 nm of 1.0. Then each strain was induced by methicillin at 0, 1, 8, or 128 mg/liter for 1 h, as described previously (10). The cells were harvested and washed with buffer (50 mM Tris, 150 mM NaCl, 5 mM MgCl2 [pH 7.5]) and then resuspended in the same buffer. Lysostaphin, DNase, and RNase were added to final concentrations of 200, 20, and 10 mg/liter, respectively, and then the mixture was incubated at 37°C for 30 min. The lysed cells were centrifuged at 4,400 × g for 10 min, and the supernatant was ultracentrifuged at 110,000 × g for 40 min. The resultant pellet was washed twice and resuspended in 50 mM phosphate buffer (pH 7.0). Membrane proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred as described previously (12). PBP2′ was detected with a mouse anti-PBP2′ monoclonal antibody (a gift of Denka Seiken Co., Ltd., Niigata, Japan) as the primary antibody (diluted 1:100,000) and alkaline phosphatase-conjugated anti-mouse immunoglobulin (Promega, Madison, Wis.). We detected bound antibodies by a color development system (Bio-Rad), as directed by the manufacturer.

Statistical analysis of data.

The statistical significance of the data was evaluated with Student's t test.

Microarray data accession number.

The transcriptional profiles of ΔIP-H5 relative to N315ΔIP and of N315 rpoB(N967I) relative to N315 are deposited in the NCBI under GEO accession number GSE42218.

RESULTS

A single amino acid substitution of rpoB(N967I) was detected in homo-MRSA strain ΔIP-H5.

To find the chr* genetic determinant, we determined the whole genomic sequence of homo-MRSA strain ΔIP-H5 (oxacillin MIC of >256 mg/liter) which had been obtained from hetero-MRSA strain N315ΔIP (oxacillin MIC of 8 mg/liter) by selection with 8 mg/liter of imipenem (30). We have already reported that the imipenem population analysis for N315ΔIP (imipenem MIC of 0.25 mg/liter) was performed, and a selective concentration of imipenem was defined as the concentration which resulted in a reduction of the initial bacterial population by approximately 4 log units (Fig. 1A) (20). The imipenem MIC increased to >32 mg/liter from 0.25 mg/liter in ΔIP-H5 (Table 2). Alignment of a 2,735,083-bp-long chromosome sequence of ΔIP-H5 with that of the parent strain N315ΔIP revealed a single mutation in the rpoB gene with the amino acid change Asn967→Ile (N967I). The amino acid substitution N967I was located outside the rifampin resistance-determining region (RRDR) (31).
Fig 1
Fig 1 Population analysis of N315 and its derivatives with exposure to imipenem (A) and methicillin (B). Pre-MRSA strain N315, hetero-type strain N315ΔIP, typical Eagle-type strain N315h4, and homo-type strain ΔIP-H5 were used as control strains. Note that N315 rpoB(N967I) showed an Eagle-type phenotype similar to that of N315h4.
Table 2
Table 2 Doubling time and antibiotic susceptibility profiles by Etest among N315 and its derived strains
StrainAmino acid and/or substitution in RpoBDoubling time (min)cMIC (mg/liter)a
METOXAIPMbRIFVANDAPLZD
N315N967 (wild type)25.1 ± 0.7140.1250.0080.751.51
N315ΔIPN967 (wild type)26.7 ± 0.51280.250.0080.751.51
ΔIP-H5N967I30.3 ± 0.9*>256>256>320.0040.7510.75
ΔIP-H14N967 (wild type)28.3 ± 1.3>256>256>320.00421.750.75
H5 rpoB(I967N)N967 (wild type)d25.4 ± 1.0660.750.0080.7510.75
N315 rpoB(N967I)N967I30.2 ± 0.3*>256 (2–12)b>256>32,(0.05–0.5)0.0040.51.50.75
N315h4R644H31.6 ± 2.4*>256 (0.75–8)b>256>32,(0.02–1.0)0.0040.7510.02
a
MET, methicillin; OXA, oxacillin; IPM, imipenem; RIF, rifampin; VAN, vancomycin; DAP, daptomycin; LZD, linezolid.
b
Eagle-type resistance was observed as the growth of the strain was inhibited at the drug concentrations shown in parentheses (Fig. 2).
c
The level of significance was determined by a two sided Student t test (*, P < 0.012) in the comparison of rpoB mutants and wild-type rpoB strains.
d
Revertant strain.

The rpoB(N967I) mutation changes phenotypic expression of β-lactam resistance.

To verify the effect of rpoB(N967I), we constructed two mutant strains, N315 rpoB(N967I) and H5 rpoB(I967N), which were derived from pre-MRSA strain N315 and homo-MRSA strain ΔIP-H5, respectively. H5 rpoB(I967N) was the reverse (or back) mutant of ΔIP-H5 that has the rpoB(N967I) mutation. We then determined the antibiograms of these mutants together with their parent strains by Etest and population analysis. As shown in Table 2, the MICs of methicillin (Fig. 2), oxacillin, and imipenem in the back-mutant strain H5 rpoB(I967N) reverted to the level of parent strain N315ΔIP. Also, the pattern of the population analysis curve for methicillin in H5 rpoB(I967N) also returned to the heterogeneous type (Fig. 1B). On the other hand, N315 rpoB(N967I) exhibited Eagle-type resistance with a unique inhibitory zone on the agar plate containing lower concentrations of methicillin (from 2 to 12 mg/liter) and grew better on the agar plates containing high concentrations of methicillin (from 12 to >256 mg/liter) (Fig. 2). The population analysis curve of N315 rpoB(N967I) showed an Eagle-type pattern similar to that of N315h4 (Fig. 1B). Other MICs for vancomycin, rifampin, and daptomycin did not change among all the tested strains, except for a decreased linezolid MIC for the Eagle-type strain N315h4 (Table 2). Eagle-type resistance occurs because of the poor induction of mecA gene expression by methicillin at lower concentrations (10). In this regard, oxacillin seemed to be a much better inducer of mecA gene transcription, and Eagle-type resistance is not clearly demonstrated by population analysis using oxacillin (data not shown). This coincides with the MIC data in Table 2: the double inhibitory zone was observed with methicillin and imipenem in the two Eagle-type strains but not with oxacillin (>256 mg/liter) (Fig. 2).
Fig 2
Fig 2 Investigation of Eagle-type phenotype for methicillin in N315 rpoB(N967I) by Etest. The hetero-type strain (pre-MRSA) N315, homo-type strain ΔIP-H5, and Eagle-type strain N315h4 were used as parent or control strains. The control strains N315, N315ΔIP, ΔIP-H5, and ΔIP-H14 and constructed mutant strain H5 rpoB(I967N) were inoculated with 108 CFU according to the manufacturer's recommendation. N315h4 and N315 rpoB(N967I) strains were inoculated with 1011 CFU. The reason for the inoculation with 1011 CFU was that the double inhibitory zone could be detected more clearly. There is no difference between MIC values with inoculum sizes of 1011 CFU and 108 CFU. An Eagle-type MRSA strain grows better on agar plates containing high concentrations of methicillin than on those with low concentrations of methicillin. The single inhibitory zone was visible with the pre-MRSA N315 and hetero-type MRSA N315ΔIP strains but not, however, with the homo-type MRSA strains.

rpoB(N967I) confers high-dose methicillin tolerance in N315.

Eagle-type strain N315h4 is known to exhibit tolerance to the killing activity of high concentrations of methicillin (10). As shown in Fig. 3, N315h4 demonstrated equivalent susceptibility to N315 to 8 mg/liter of methicillin. However, N315h4 exhibited reduced susceptibility to the cytokilling activity of methicillin at 128 mg/liter. This high-dose methicillin tolerance was also observed with N315 rpoB(N967I) (Fig. 3). Homo-MRSA strain ΔIP-H5 is resistant to high concentrations of methicillin, so it increases in cell number in the presence of 128 mg/liter of methicillin. On the other hand, ΔIP-H5 rpoB(I967N) harboring the reverted wild-type rpoB gene lost both resistance and tolerance to methicillin and returned to the pattern of the cytokilling profile of N315ΔIP (Fig. 3). Thus, the mutation rpoB(N967I) was shown to confer on the cells tolerance to high doses of methicillin.
Fig 3
Fig 3 Effect of rpoB on methicillin-induced killing. The tested strains were hetero-type strains N315, N315ΔIP, and H5 rpoB(I967N), Eagle-type strains N315h4 and N315 rpoB(N967I), and homo-type strain ΔIP-H5. The killing assay was performed in the presence of methicillin at concentrations of 0 (○), 1 (▲), 8 (X), and 128 (●) mg/liter. The viable cell counts were done at 0, 1, 2, and 4 h after the start of culture.

PBP2′ production in the rpoB mutant strains in response to methicillin.

To verify the amount of PBP2′ in all of the tested strains, we performed Western blot analysis for PBP2′. The amount of PBP2′ was measured before and after exposure to 1, 8, or 128 mg/liter of methicillin for 1 h (Fig. 4). We have already reported that N315 produced a very low-level amount of PBP2′ before induction with methicillin because of the mecI gene-mediated repression of mecA gene transcription (12). In contrast, N315ΔIP was found to produce detectable amounts of PBP2′ without methicillin induction because PBP2′ production was derepressed by the absence of mecI gene (Fig. 4). PBP2′ was produced constitutively in homo-MRSA ΔIP-H5 and hetero-MRSA H5 rpoB(I967N) in the absence of the mecI repressor gene of mecA, both before and after induction with methicillin (Fig. 4).
Fig 4
Fig 4 Western blot analysis for expression of mecA after 1 h of induction with methicillin. PBP2′ production induced by methicillin at 0, 1, 8, and 128 mg/liter is shown in lanes 1 to 4, respectively, for each strain. The pre-MRSA N315 and Eagle-type MRSA strains N315h4 and N315 rpoB(N967I) carried intact mecI repressor genes of mecA. In the N315 and two Eagle-type strains, the amount of PBP2′ was increased under the condition of induction with methicillin at 8 and 128 mg/liter (lanes 3 and 4) compared to levels with methicillin at 0 and 1 mg/liter (lanes 1 and 2), respectively.
The PBP2′ production in the two Eagle-type MRSA strains N315h4 and N315 rpoB(N967I) was also repressed both before and after induction with 0 and 1 mg/liter of methicillin, as described previously (10). Induction with 8 and 128 mg/liter of methicillin was able to induce PBP2′ production appreciably.

Eagle-type strain N315h4 carries the rpoB(R644H) mutation.

To investigate the genetic alteration responsible for the Eagle-type resistance of N315h4, we determined its whole genome sequence and compared it with that of N315. We found only one mutation in rpoB in the N315h4 chromosome, and no other mutation was found. However, the amino acid position and substitution were different from those of ΔIP-H5, which carried R644H. Thus, certain rpoB mutations are capable of conferring high-dose methicillin tolerance and homo- as well as Eagle-type methicillin resistance.

Both rpoB(N967I) and rpoB(R644H) mutations prolong the doubling time and bring about thickening of the cell wall.

All three rpoB mutant strains, N315 rpoB(N967I), N315h4, and ΔIP-H5, had prolonged doubling times compared with their parent strain N315 or with N315ΔIP carrying the wild-type rpoB gene (Table 2). Electron microscopic observation revealed that ΔIP-H5 had a thicker cell wall (21.6 ± 1.8 nm) than N315ΔIP (17.7 ± 1.5 nm) and its back-mutant strain H5 rpoB(I967N) (14.2 ± 1.2 nm). The cell wall of Eagle-type strains N315h4 (20.2 ± 1.8 nm) and N315 rpoB(N967I) (17.2 ± 1.8 nm) were thicker than the cell wall of the parent strain N315 (14.1 ± 1.3 nm). The significant difference between the rpoB mutant strains and wild-type rpoB strains was determined by a two-sided Student's t test (P < 0.018). The results indicated that the doubling time prolongation and cell wall thickening were associated with the rpoB(N967I) mutation.

Transcriptional profiles were changed by the rpoB(N967I) mutation.

Microarray analysis of ΔIP-H5 and N315 rpoB(N967I) revealed 147 and 163 differentially expressed genes, respectively, compared to the parent strains. Among the genes, 33 downregulated and 38 upregulated genes, respectively, were commonly found in ΔIP-H5 (compared to N315ΔIP) and N315 rpoB(N967I) (compared to N315), except for sa2430 encoding the zinc metalloproteinase aureolysin (Table 3). With reference to the tolerance phenotype of the rpoB(N967I) mutation, we noticed a change in expression of the genes involved in autolysin activity and the cell wall synthesis function. The transcriptional level of cidABC encoding the complex up-regulatory system for autolysin activity (3236) was decreased by 0.42-, 0.48-, and 0.44-fold in ΔIP-H5 relative to N315ΔIP and by 0.25-, 0.27-, 0.26-fold in N315 rpoB(N967I) relative to N315, respectively. On the other hand, the expression levels of the negative regulators of autolysis, lrgAB (35, 37), were increased by 2.53- and 2.08-fold in ΔIP-H5 relative to N315ΔIP and by 6.60- and 6.57-fold in N315 rpoB(N967I) relative to N315, respectively.
Table 3
Table 3 Alterations of transcription for ΔIP-H5 versus N315ΔIP and N315 rpoB(N967I) versus N315
Function and ORFaGeneProductbRatio of signal intensity (mutant to parent strain)
ΔIP-H5/N315ΔIPN315rpoB(N967I)/N315
Environmental information processing    
    Autolysin-associated genes and regulators    
        SA0252lrgAHolin-like protein; murein hydrolase regulator LrgA2.536.57
        SA0253lrgBAntiholin-like protein LrgB2.086.60
        SA2327cidCRegulatory protein for murein hydrolase activity0.440.26
        SA2328cidBRegulatory protein for murein hydrolase activity0.480.27
        SA2329cidARegulatory protein for murein hydrolase activity0.420.25
        SA1898sceD-likeSimilar to SceD protein, predicted to be a lytic transglycosylase2.213.26
    Other signal transduction and regulators    
        SA2090rsrRepressor of sarR and agr genes0.300.38
        SA2091sarYStaphylococcal accessory regulator Y0.220.31
        SA2092 Similar to transcription regulator AraC type regulator0.200.35
Metabolism    
    Cell-wall biosynthesis and metabolism    
        SA0124 Similar to glycosyltransferase TuaA0.390.43
        SA0125 Similar to exopolysaccharide G (EpsG)0.350.40
        SA0523 Similar to poly(glycerol-phosphate) alpha-glucosyltransferase2.032.33
        SA1964fmtB (mrp)Cell surface protein; inactivation reduces MET resistance0.240.29
    Cell envelope biogenesis    
        SA0126 Similar to capsular polysaccharide synthesis protein 14H0.390.43
        SA0127 Similar to capsular polysaccharide synthesis protein 14L0.470.50
    Carbon hydrate metabolism    
    Nitrogen metabolism    
    Energy metabolism    
    Nucleotide transport and metabolism    
        SA1047pyrFOrotidine-5-phosphate decarboxylase0.340.48
        SA1172 Similar to GMP reductase0.320.47
    Sugar transport and metabolism    
        SA0837 Similar to 2-isopropylmalate synthase2.952.86
        SA1991lacG6-Phospho-beta-galactosidase0.290.23
        SA1992lacEPTS system, lactose-specific IIBC component0.290.25
        SA1993lacFPTS system, lactose-specific IIA component0.340.19
        SA1994lacDTagatose-1,6-diphosphate aldolase0.360.21
        SA1995lacCTagatose-6-phosphate kinase0.420.21
        SA1996lacBGalactose-6-phosphate isomerase LacB subunit0.490.25
        SA2486 2-Oxoglutarate/malate translocator homolog2.132.03
    Amino acid transport and metabolism    
        SA0822argGArgininosuccinate synthase0.400.48
        SA0850 Similar to oligopeptide ABC transporter oligopeptide-binding protein0.270.44
    Terpenoid metabolism    
        SA1304 Similar to component A of hexaprenyl diphosphate synthase2.242.19
    Secretion and other transport system    
        SA0956 Similar to Mn2+ transport protein0.200.32
        SA2203mdeASimilar to multidrug resistance protein2.362.14
        SA2442secA2Preprotein translocase secA homolog2.312.18
        SA2443asp3Accessory secretory protein Asp33.103.20
        SA2444asp2Accessory secretory protein Asp23.893.36
        SA2445asp1Accessory secretory protein Asp15.934.04
        SA2446secY2Similar to preprotein translocase secY5.514.01
Genetic information processing    
    SA0706 Similar to comF operon protein 32.343.16
    SA1899 Similar to single-strand DNA binding protein2.412.56
Virulence factor    
    SA0393ssl11Exotoxin 150.310.23
    SA0519sdrCSer-Asp-rich fibrinogen-binding, bone sialoprotein-binding protein2.593.48
    SA0520sdrDSer-Asp-rich fibrinogen-binding, bone sialoprotein-binding protein2.263.45
    SA0521sdrESer-Asp-rich fibrinogen-binding, bone sialoprotein-binding protein4.454.60
    SA1267ebhAExtracellular matrix-binding protein EbhA0.220.11
    SA1577sasCS. aureus surface protein C0.360.40
    SA2423clfBClumping factor B4.582.49
    SA2430aurZinc metalloproteinase aureolysin0.403.50
Hypothetical protein    
    SA0262 Hypothetical protein2.182.35
    SA0266 Conserved hypothetical protein2.172.16
    SA0267 Hypothetical protein2.102.21
    SA0268 Hypothetical protein2.072.74
    SA0269 Hypothetical protein2.002.30
    SA0271 Conserved hypothetical protein2.413.90
    SA0275 Conserved hypothetical protein2.182.16
    SA0331 Conserved hypothetical protein0.310.33
    SA0332 Conserved hypothetical protein0.230.35
    SA0333 Conserved hypothetical protein0.260.35
    SA0394 Hypothetical protein0.300.24
    SA0663 Hypothetical protein0.320.48
    SA0737 Hypothetical protein2.902.28
    SA0738 Hypothetical protein2.552.37
    SA0739 Conserved hypothetical protein2.865.11
    SA0741 Conserved hypothetical protein3.934.14
    SA0742 Hypothetical protein3.743.29
    SA0761 Conserved hypothetical protein2.546.06
    SA0830 Conserved hypothetical protein2.492.63
    SA1002 Hypothetical protein2.403.25
    SA1049 Hypothetical protein0.410.37
    SA1222 Hypothetical protein2.042.49
    SA1268 Hypothetical protein0.360.25
    SA1664 Conserved hypothetical protein2.222.23
    SA1755 Hypothetical protein (bacteriophage ϕN315)0.250.188
    SA2299 Conserved hypothetical protein2.702.04
    SA2491 Conserved hypothetical protein2.492.55
a
Locus tags are based on S. aureus strain N315. ORF, open reading frame.
b
MET, methicillin; PTS, phosphotransferase system.

The effect of rpoB(N967I) on Triton X-100-stimulated autolytic activity.

To observe the effect of rpoB(N967I) on the regulation of the genes involved in autolysis, we tested Triton X-100-induced autolysis of the rpoB(N967I) mutant strains (Fig. 5). The two rpoB(N967I) mutants, N315 rpoB(N967I) and ΔIP-H5, had significantly decreased Triton X-100-induced autolysis rates (50% lysis in about 100 to 110 min) compared to their parent strains N315 and N315ΔIP (50% lysis in 40 to 60 min). Moreover, N315h4 carrying rpoB(R644H) also exhibited a decrease in autolysis compared to the parent strain N315. These results indicated that the rpoB(N967I) and rpoB(R644H) mutations were correlated with the level of autolytic activity in S. aureus.
Fig 5
Fig 5 Triton X-100 (0.05%)-stimulated autolysis of three wild-type rpoB strains, N315, N315ΔIP, H5 rpoB(N967I), and their three rpoB mutant strains, N315 rpoB(N967I), N315h4 and ΔIP-H5. Autolysis was measured as the decline in optical density versus time and is expressed as the percentage of the initial optical density. The data presented are representative of three independent experiments.

DISCUSSION

This study demonstrated that two mutations in the RNA polymerase β subunit, rpoB(N967I) and rpoB(R644H), cause heterogenous-to-homogeneous and heterogeneous-to-Eagle-type phenotypic conversion of methicillin resistance. These rpoB mutations would constitute an important category of chr* mutations (6). RpoB has been well known as the target of rifampin. The mutation of rpoB has been assigned significance only as the resistance marker for rifampin. However, we noticed a variety of rpoB mutations that affected various important antibiotics other than rifampin. In addition to rifampin resistance, rpoB(H481Y) raises vancomycin resistance and promotes the heterogeneous vancomycin-intermediate S. aureus (hVISA)-to-VISA conversion (20, 22). rpoB(Q468K) raises resistance to both rifampin and daptomycin (22). The rpoB mutations such as rpoB(T480M) and rpoB(R503H) do not affect rifampin susceptibility (MICs of 0.016 and 0.031, respectively), whereas they are associated with the raised resistance to teicoplanin, vancomycin, and daptomycin (22).
The rpoB mutations causing either VISA or daptomycin resistance are commonly associated with such phenotypes as prolonged doubling time and increased linezolid susceptibility (23, 24, 38). As shown here, the two rpoB mutations promoting the conversion of heterogenous to homogeneous methicillin resistance also share the same features of prolonged doubling time and increased linezolid susceptibility. Introduction of an rpoB(H481Y) mutation causes thickening of the cell wall, which is the cardinal feature of the VISA phenotype (22). rpoB(N967I) also had this effect. It seems that cell wall thickening is a common feature of rpoB mutation. However, the cell wall thickening by rpoB(N967I) did not accompany an increase in vancomycin resistance, as was the case with the rpoB(H481Y) mutation (20, 22).
Interestingly, microarray results of ΔIP-H5 relative to those with N315ΔIP showed that the transcriptional level of cidABC encoding a complex upregulatory system for autolysin activity was decreased. In contrast, the expression level of the negative regulator of autolysis, lrgAB, was increased. Furthermore, the autolytic activity was decreased in the rpoB(N967I) mutants shown in Fig. 4. The S. aureus cidABC operon is reported to encode a complex regulatory system that affects murein hydrolase activity, antibiotic tolerance, and cell viability in stationary phase (3235, 3941). Disruption of the cid operon causes decreased murein hydrolase activity and increased tolerance to antibiotics, whereas an lrg mutation causes increased murein hydrolase activity and decreased antibiotic tolerance (3335). It is suggested that rpoB mutations decrease autolysis by modulating the expression of lrg and cid operons.
In N315 with its mecA gene expression strongly repressed by MecI, cells are killed by the presence of high concentrations of methicillin (Fig. 3). However, as illustrated in Fig. 6, rpoB(N967I) and rpoB(R644H) mutations allow the cell to tolerate the presence of methicillin and receive the benefit of PBP2′, which is induced only by high concentrations of methicillin (Fig. 4 and Fig. 5). The mutations make N315 express Eagle-type resistance. When the same mutations occur in N315ΔIP, in which the mecA gene is constitutively transcribed, homogeneous methicillin resistance is expressed as with strain ΔIP-H5 (Fig. 4 and Fig. 5).
Fig 6
Fig 6 Schematic diagram of methicillin phenotypic conversion by population analysis. Two pathways of acquisition of homo-type methicillin resistance from pre-MRSA strain N315. Two genetic alterations, mecI inactivation and mutated rpoB [rpoB(N967I) or rpoB(R644H), indicated on the figure as rpoB*] as a chr* mutation, are required for N315 to achieve homo-type methicillin resistance. Eagle-type methicillin resistance was reproduced by mutated rpoB under the presence of mecI activation. conc, concentration.
rpoB mutations are responsible for the progression of vancomycin resistance from hetero-VISA to VISA (21, 22). Here, we showed that two rpoB mutations cause heterogeneous-to-homogeneous conversion of methicillin resistance. We consider that the rpoB mutation is a major cause of the phenotype of high resistance to both methicillin and vancomycin. The locations of the mutations in the rpoB gene and the kinds of amino acid substitutions would confer on the cell not only resistance to various combinations of antibiotics but also various degrees of resistance (Fig. 6). The characteristic shape of the population curve of hetero-MRSA strains would thus be explained by the presence of cells with various rpoB mutations.
In addition to vancomycin, rifampin also can select VISA out of hetero-VISA strains (21, 22). This illustrates that some rpoB mutations confer cross-resistance to both vancomycin and rifampin. To test if this is also the case for β-lactam and rifampin, we obtained 50 rpoB mutants by selecting hetero-MRSA strain N315ΔIP with rifampin. We found three of these mutants were converted to homo-MRSA (Yuki Katayama, unpublished data). Thus, the rpoB gene seems to be a key target of mutations that modulate the resistance phenotype to various antibiotics. Exhaustive listing of rpoB gene mutations and their roles in antibiotic resistance expression would be worthwhile.

ACKNOWLEDGMENTS

This study was supported by a Grant-in-Aid for Young Scientists (B 24791029) and a Grant-in-Aid (S1201013) from the Ministry of Education, Culture, Sports, Science and Technology Japan for the Foundation of Strategic Research Projects in Private Universities.
We thank Mitutaka Yoshida (Division of Ultrastructural Research, Juntendo University) for invaluable help in sample preparation and technical support of transmission electron microscopy and Hui-min Neoh (Juntendo University School of Medicine) and Rukmoni Soren (Indian Institute of Technology, Kharagpur, India) for great technical assistance.

REFERENCES

1.
Song MD, Wachi M, Doi M, Ishino F, and Matsuhashi M. 1987. Evolution of an inducible penicillin-target protein in methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett. 221:167–171.
2.
Utsui Y, Inoue M, and Mitsuhashi S. 1987. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin. Antimicrob. Agents Chemother. 31:1085–1092.
3.
Hartman BJ and Tomasz A. 1984. Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus. J. Bacteriol. 158:513–516.
4.
Blanchard TJ, Poston SM, and Reynolds PJ. 1986. Recipient characteristics in the transduction of methicillin resistance in Staphylococcus epidermidis. Antimicrob. Agents Chemother. 29:539–541.
5.
Matsuhashi M, Song MD, Ishino F, Wachi M, Doi M, Inoue M, Ubukata K, Yamashita N, and Konno M. 1986. Molecular cloning of the gene of a penicillin-binding protein supposed to cause high resistance to beta-lactam antibiotics in Staphylococcus aureus. J. Bacteriol. 167:975–980.
6.
Ryffel C, Strassle A, Kayser FH, and Berger-Bachi B. 1994. Mechanisms of heteroresistance in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 38:724–728.
7.
Berger-Bachi B and Rohrer S. 2002. Factors influencing methicillin resistance in staphylococci. Arch. Microbiol. 178:165–171.
8.
Eagle H and Musselman AD. 1948. The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms. J. Exp. Med. 88:99–131.
9.
Eagle H. 1948. A paradoxical zone phenomenon in the bactericidal action of penicillin in vitro. Science 107:44–45.
10.
Kondo N, Kuwahara-Arai K, Kuroda-Murakami H, Tateda-Suzuki E, and Hiramatsu K. 2001. Eagle-type methicillin resistance: new phenotype of high methicillin resistance under mec regulator gene control. Antimicrob. Agents Chemother. 45:815–824.
11.
Hiramatsu K, Asada K, Suzuki E, Okonogi K, and Yokota T. 1992. Molecular cloning and nucleotide sequence determination of the regulator region of mecA gene in methicillin-resistant Staphylococcus aureus (MRSA). FEBS Lett. 298:133–136.
12.
Kuwahara-Arai K, Kondo N, Hori S, Tateda-Suzuki E, and Hiramatsu K. 1996. Suppression of methicillin resistance in a mecA-containing pre-methicillin-resistant Staphylococcus aureus strain is caused by the mecI-mediated repression of PBP 2′ production. Antimicrob. Agents Chemother. 40:2680–2685.
13.
Tesch W, Ryffel C, Strassle A, Kayser FH, and Berger-Bachi B. 1990. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob. Agents Chemother. 34:1703–1706.
14.
Ito T, Katayama Y, and Hiramatsu K. 1999. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob. Agents Chemother. 43:1449–1458.
15.
Katayama Y, Ito T, and Hiramatsu K. 2001. Genetic organization of the chromosome region surrounding mecA in clinical staphylococcal strains: role of IS431-mediated mecI deletion in expression of resistance in mecA-carrying, low-level methicillin-resistant Staphylococcus haemolyticus. Antimicrob. Agents Chemother. 45:1955–1963.
16.
International Working Group on the Classification of Staphylococcal Cassette Chromosome Elements (IWG-SCC). 2009. Classification of staphylococcal cassette chromosome mec (SCCmec): guidelines for reporting novel SCCmec elements. Antimicrob. Agents Chemother. 53:4961–4967.
17.
Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H, and Spratt BG. 2002. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc. Natl. Acad. Sci. U. S. A. 99:7687–7692.
18.
Fujimura T and Murakami K. 1997. Increase of methicillin resistance in Staphylococcus aureus caused by deletion of a gene whose product is homologous to lytic enzymes. J. Bacteriol. 179:6294–6301.
19.
Maki H and Murakami K. 1997. Formation of potent hybrid promoters of the mutant llm gene by IS256 transposition in methicillin-resistant Staphylococcus aureus. J. Bacteriol. 179:6944–6948.
20.
Katayama Y, Murakami-Kuroda H, Cui L, and Hiramatsu K. 2009. Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem. Antimicrob. Agents Chemother. 53:3190–3196.
21.
Watanabe Y, Cui L, Katayama Y, Kozue K, and Hiramatsu K. 2011. Impact of rpoB mutations on reduced vancomycin susceptibility in Staphylococcus aureus. J. Clin. Microbiol. 49:2680–2684.
22.
Matsuo M, Hishinuma T, Katayama Y, Cui L, Kapi M, and Hiramatsu K. 2011. Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3. Antimicrob. Agents Chemother. 55:4188–4195.
23.
Camargo IL, Neoh HM, Cui L, and Hiramatsu K. 2008. Serial daptomycin selection generates daptomycin-nonsusceptible Staphylococcus aureus strains with a heterogeneous vancomycin-intermediate phenotype. Antimicrob. Agents Chemother. 52:4289–4299.
24.
Cui L, Isii T, Fukuda M, Ochiai T, Neoh HM, Camargo IL, Watanabe Y, Shoji M, Hishinuma T, and Hiramatsu K. 2010. An RpoB mutation confers dual heteroresistance to daptomycin and vancomycin in Staphylococcus aureus. Antimicrob. Agents Chemother. 54:5222–5233.
25.
Katayama Y, Takeuchi F, Ito T, Ma XX, Ui-Mizutani Y, Kobayashi I, and Hiramatsu K. 2003. Identification in methicillin-susceptible Staphylococcus hominis of an active primordial mobile genetic element for the staphylococcal cassette chromosome mec of methicillin-resistant Staphylococcus aureus. J. Bacteriol. 185:2711–2722.
26.
Bae T and Schneewind O. 2006. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid 55:58–63.
27.
Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, and Hiramatsu K. 1998. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J. Antimicrob. Chemother. 42:199–209.
28.
Gustafson JE, Berger-Bachi B, Strassle A, and Wilkinson BJ. 1992. Autolysis of methicillin-resistant and -susceptible Staphylococcus aureus. Antimicrob. Agents Chemother. 36:566–572.
29.
Cui L, Lian JQ, Neoh HM, Reyes E, and Hiramatsu K. 2005. DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 49:3404–3413.
30.
Kuroda M, Kuroda H, Oshima T, Takeuchi F, Mori H, and Hiramatsu K. 2003. Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus. Mol. Microbiol. 49:807–821.
31.
Campbell EA, Korzheva N, Mustaev A, Murakami K, Nair S, Goldfarb A, and Darst SA. 2001. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104:901–912.
32.
Brunskill EW and Bayles KW. 1996. Identification of LytSR-regulated genes from Staphylococcus aureus. J. Bacteriol. 178:5810–5812.
33.
Groicher KH, Firek BA, Fujimoto DF, and Bayles KW. 2000. The Staphylococcus aureus lrgAB operon modulates murein hydrolase activity and penicillin tolerance. J. Bacteriol. 182:1794–1801.
34.
Rice KC, Firek BA, Nelson JB, Yang SJ, Patton TG, and Bayles KW. 2003. The Staphylococcus aureus cidAB operon: evaluation of its role in regulation of murein hydrolase activity and penicillin tolerance. J. Bacteriol. 185:2635–2643.
35.
Rice KC, Nelson JB, Patton TG, Yang SJ, and Bayles KW. 2005. Acetic acid induces expression of the Staphylococcus aureus cidABC and lrgAB murein hydrolase regulator operons. J. Bacteriol. 187:813–821.
36.
Patton TG, Rice KC, Foster MK, and Bayles KW. 2005. The Staphylococcus aureus cidC gene encodes a pyruvate oxidase that affects acetate metabolism and cell death in stationary phase. Mol. Microbiol. 56:1664–1674.
37.
Trotonda MP, Xiong YQ, Memmi G, Bayer AS, and Cheung AL. 2009. Role of mgrA and sarA in methicillin-resistant Staphylococcus aureus autolysis and resistance to cell wall-active antibiotics. J. Infect. Dis. 199:209–218.
38.
Komoto A, Cui L, Ebata N, Watanabe Y, Matsuo M, Katayama Y, Petcharoen P, and Hiramatsu K. 2012. The mutation of rpoB gene encoding beta-subunit of RNA polymerase is associated with improvement of linezolid susceptibility in Staphylococcus aureus. Juntendo Med. J. 58:498–505.
39.
Rice KC, Patton T, Yang SJ, Dumoulin A, Bischoff M, and Bayles KW. 2004. Transcription of the Staphylococcus aureus cid and lrg murein hydrolase regulators is affected by sigma factor B. J. Bacteriol. 186:3029–3037.
40.
Patton TG, Yang SJ, and Bayles KW. 2006. The role of proton motive force in expression of the Staphylococcus aureus cid and lrg operons. Mol. Microbiol. 59:1395–1404.
41.
Yang SJ, Rice KC, Brown RJ, Patton TG, Liou LE, Park YH, and Bayles KW. 2005. A LysR-type regulator, CidR, is required for induction of the Staphylococcus aureus cidABC operon. J. Bacteriol. 187:5893–5900.

Information & Contributors

Information

Published In

cover image Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy
Volume 57Number 10October 2013
Pages: 4861 - 4871
PubMed: 23877693

History

Received: 23 April 2013
Returned for modification: 14 May 2013
Accepted: 14 July 2013
Published online: 13 September 2013

Contributors

Authors

Yoshifumi Aiba
Department of Infection Control Science, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Yuki Katayama
Department of Bacteriology, Faculty of Medicine, Juntendo University, Tokyo, Japan
Tomomi Hishinuma
Department of Bacteriology, Faculty of Medicine, Juntendo University, Tokyo, Japan
Hiroko Murakami-Kuroda
Department of Bacteriology, Faculty of Medicine, Juntendo University, Tokyo, Japan
Longzhu Cui
Department of Bacteriology, Faculty of Medicine, Juntendo University, Tokyo, Japan
Present address: Longzhu Cui, Research Center for Infections and Antimicrobials, Kitasato Institute for Life Science, Kitasato University, Tokyo, Japan.
Keiichi Hiramatsu
Department of Infection Control Science, Graduate School of Medicine, Juntendo University, Tokyo, Japan
Department of Bacteriology, Faculty of Medicine, Juntendo University, Tokyo, Japan

Notes

Address correspondence to Yuki Katayama, [email protected].

Metrics & Citations

Metrics

Note:

  • For recently published articles, the TOTAL download count will appear as zero until a new month starts.
  • There is a 3- to 4-day delay in article usage, so article usage will not appear immediately after publication.
  • Citation counts come from the Crossref Cited by service.

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. For an editable text file, please select Medlars format which will download as a .txt file. Simply select your manager software from the list below and click Download.

View Options

Figures and Media

Figures

Media

Tables

Share

Share

Share the article link

Share with email

Email a colleague

Share on social media

American Society for Microbiology ("ASM") is committed to maintaining your confidence and trust with respect to the information we collect from you on websites owned and operated by ASM ("ASM Web Sites") and other sources. This Privacy Policy sets forth the information we collect about you, how we use this information and the choices you have about how we use such information.
FIND OUT MORE about the privacy policy